|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 14/51 | (2006.01) | ||
| A61K 38/10 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C12N 15/63 | (2006.01) |
| (11) | Number of the document | 2298800 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10014361.9 |
| Date of filing the European patent application | 2006-04-28 | |
| (97) | Date of publication of the European application | 2011-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 677583 P | 2005-05-03 | US | |
| 776847 P | 2006-02-24 | US | |
| 782244 P | 2006-03-13 | US | |
| 792645 P | 2006-04-17 | US | |
| 410540 | 2006-04-25 | US |
| (72) |
Lu, Hsieng Sen, US
Paszty, Christopher, US
Robinson, Martyn Kim, GB
Henry, Alistair James, GB
Hoffmann, Kelly Sue, US
Latham, John, US
Lawson, Alastair, GB
Winkler, David, US
Winters, Aaron George, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | Sclerostin binding antibodies |
| Sclerostin binding antibodies |